简
/
繁
/
EN
About Us
R&D
Products
News
Careers
Investors
Contact us
Investors
（02186.HK）
HK$
➚
%
Volume(M)
0thousand
Turnover(HK $)
0thousand
Data as of：
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact IR
Year
2022
2023
2024
2025
10
2023-03
Notice of Board Meeting
01
2023-03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
12
2023-02
List of Directors and their Roles and Functions
12
2023-02
Passing Away of a Non-Executive Director
06
2023-02
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
25
2023-01
Stabilizing Actions, End of Stabilization Period and Lapse of the Over-Allotment Option
10
2023-01
Voluntary Announcement Grant of Exclusive Commercialization Rights of Boyoubei in Mainland China to CP Qingdao
09
2023-01
Voluntary Announcement Approval Obtained for Initiating Clinical Trial for the Innovative ADC Candidate BA1301 for Injection in China
06
2023-01
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
29
2022-12
List of Directors and their Roles and Functions
9
10
11
12
13
Follow me
鲁公网安备37069102000284